Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 41

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis

Heinrich, Maxwell J., Purcell, Caroline A., Pruijssers, Andrea J., Zhao, Yang, Spurlock, Charles F., Sriram, Subramaniam, Ogden, Kristen M., Dermody, Terence S., Scholz, Matthew B., Crooke, Philip S., Karijolich, John, Aune, Thomas M. · 2019 · Journal of Autoimmunity

Abstract

Various sensors that detect double-stranded RNA, presumably of viral origin, exist in eukaryotic cells and induce IFN-responses. Ongoing IFN-responses have also been documented in a variety of human autoimmune diseases including relapsing-remitting multiple sclerosis (RRMS) but their origins remain obscure. We find increased IFN-responses in leukocytes in relapsing-remitting multiple sclerosis at distinct stages of disease. Moreover, endogenous RNAs isolated from blood cells of these same patients recapitulate this IFN-response if transfected into naïve cells. These endogenous RNAs are double-stranded RNAs, contain Alu and Line elements and are transcribed from leukocyte transcriptional enhancers. Thus, transcribed endogenous retrotransposon elements can co-opt pattern recognition sensors to induce IFN-responses in RRMS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaut.2019.02.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 63

  1. Medzhitov, 2001, Toll-like receptors and innate immunity, Nat. Rev. Immunol., 1, 135, 10.1038/35100529 · DOI · Paper page
  2. Medzhitov, 2000, Innate immune recognition: mechanisms and pathways, Immunol. Rev., 173, 89, 10.1034/j.1600-065X.2000.917309.x · DOI · Paper page
  3. Janeway, 2002, Innate immune recognition, Annu. Rev. Immunol., 20, 197, 10.1146/annurev.immunol.20.083001.084359 · DOI · Paper page
  4. Medzhitov, 1998, Innate immune recognition and control of adaptive immune responses, Semin, Immunology, 10, 351
  5. Der, 1998, Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays, Proc. Natl. Acad. Sci. U. S. A, 95, 15623, 10.1073/pnas.95.26.15623 · DOI · Paper page
  6. Kalvakolanu, 1996, An overview of the interferon system: signal transduction and mechanisms of action, Canc. Invest., 14, 25, 10.3109/07357909609018435 · DOI
  7. Pestka, 2004, Interferons, interferon-like cytokines, and their receptors, Immunol. Rev., 202, 8, 10.1111/j.0105-2896.2004.00204.x · DOI · Paper page
  8. Biron, 2001, Interferons alpha and beta as immune regulators - a new look, Immunity, 14, 661, 10.1016/S1074-7613(01)00154-6 · DOI · Paper page
  9. Samuel, 2001, Antiviral actions of interferons, Clin. Microbiol. Rev., 14, 778, 10.1128/CMR.14.4.778-809.2001 · DOI · Paper page
  10. Trinchieri, 2010, Type I interferon: friend or foe?, J. Exp. Med., 207, 2053, 10.1084/jem.20101664 · DOI · Paper page
  11. Schoggins, 2011, A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, 472, 481, 10.1038/nature09907 · DOI · Paper page
  12. Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
  13. Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med., 197, 711, 10.1084/jem.20021553 · DOI · Paper page
  14. Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc. Natl. Acad. Sci. U. S. A, 100, 10.1073/pnas.0337679100 · DOI · Paper page
  15. Lubbers, 2013, The type I IFN signature as a biomarker of preclinical rheumatoid arthritis, Ann. Rheum. Dis., 72, 776, 10.1136/annrheumdis-2012-202753 · DOI · Paper page
  16. Verweij, 2013, Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy, Discov. Med., 15, 51
  17. Crow, 2014, Type I interferon in the pathogenesis of lupus, J. Immunol., 192, 5459, 10.4049/jimmunol.1002795 · DOI · Paper page
  18. Sharma, 2015, Nucleic acid-sensing receptors: rheostats of autoimmunity and autoinflammation, J. Immunol., 195, 3507, 10.4049/jimmunol.1500964 · DOI
  19. Jimenez-Dalmaroni, 2016, The critical role of toll-like receptors - from microbial recognition to autoimmunity: a comprehensive review, Autoimmun. Rev., 15, 1, 10.1016/j.autrev.2015.08.009 · DOI · Paper page
  20. Nezos, 2015, Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis, J. Autoimmun., 63, 47, 10.1016/j.jaut.2015.07.002 · DOI · Paper page
  21. Ranoa, 2016, Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs, Oncotarget, 7, 26496, 10.18632/oncotarget.8420 · DOI · Paper page
  22. Belair, 2018, Noncoding RNA surveillance: the ends justify the means, Chem. Rev., 118, 4422, 10.1021/acs.chemrev.7b00462 · DOI
  23. Portal, 2015, Human cells contain natural double-stranded RNAs with potential regulatory functions, Nat. Struct. Mol. Biol., 22, 89, 10.1038/nsmb.2934 · DOI
  24. Hung, 2015, The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression, Science, 350, 455, 10.1126/science.aac7442 · DOI · Paper page
  25. Houseley, 2009, The many pathways of RNA degradation, Cell, 136, 763, 10.1016/j.cell.2009.01.019 · DOI · Paper page
  26. Mighell, 1997, Alu sequences, FEBS Lett., 417, 1, 10.1016/S0014-5793(97)01259-3 · DOI
  27. Deininger, 2011, Alu elements: know the SINEs, Genome Biol., 12, 236, 10.1186/gb-2011-12-12-236 · DOI · Paper page
  28. Marullo, 2010, Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data, Genome Biol., 11, R9, 10.1186/gb-2010-11-1-r9 · DOI
  29. Spurlock, 2015, Defective structural RNA processing in relapsing-remitting multiple sclerosis, Genome Biol., 16, 58, 10.1186/s13059-015-0629-x · DOI
  30. Tossberg, 2012, Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis, Genes Immun., 13, 146, 10.1038/gene.2011.66 · DOI
  31. Tossberg, 2013, Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis, J. Clin. Bioinf., 3, 18, 10.1186/2043-9113-3-18 · DOI
  32. Spurlock, 2017, Profiles of long noncoding RNAs in human naive and memory T cells, J. Immunol., 199, 547, 10.4049/jimmunol.1700232 · DOI
  33. Spurlock, 2015, Expression and functions of long noncoding RNAs during human T helper cell differentiation, Nat. Commun., 6, 6932, 10.1038/ncomms7932 · DOI · Paper page
  34. Soutto, 2002, Cutting edge: distal regulatory elements are required to achieve selective expression of IFN-gamma in Th1/Tc1 effector cells, J. Immunol., 169, 6664, 10.4049/jimmunol.169.12.6664 · DOI
  35. Schonborn, 1991, Monoclonal-antibodies to double-stranded-RNA as probes of RNA structure in crude nucleic-acid extracts, Nucleic Acids Res., 19, 2993, 10.1093/nar/19.11.2993 · DOI · Paper page
  36. Bolger, 2014, Trimmomatic: a flexible trimmer for Illumina sequence data, Bioinformatics, 30, 2114, 10.1093/bioinformatics/btu170 · DOI · Paper page
  37. Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinf., 12, 323, 10.1186/1471-2105-12-323 · DOI · Paper page
  38. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  39. Jurka, 2000, Repbase Update - a database and an electronic journal of repetitive elements, Trends Genet., 16, 418, 10.1016/S0168-9525(00)02093-X · DOI · Paper page
  40. Aune, 2017, Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants, J. Autoimmun., 81, 99, 10.1016/j.jaut.2017.03.014 · DOI
  41. Wang, 2013, VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data, PLoS One, 8, e64465, 10.1371/journal.pone.0064465 · DOI · Paper page
  42. Robinson, 2011, Integrative genomics viewer, Nat. Biotechnol., 29, 24, 10.1038/nbt.1754 · DOI · Paper page
  43. Hnisz, 2013, Super-enhancers in the control of cell identity and disease, Cell, 155, 934, 10.1016/j.cell.2013.09.053 · DOI · Paper page
  44. Natoli, 2012, Noncoding transcription at enhancers: general principles and functional models, Annu. Rev. Genet., 46, 1, 10.1146/annurev-genet-110711-155459 · DOI · Paper page
  45. Pott, 2015, What are super-enhancers?, Nat. Genet., 47, 8, 10.1038/ng.3167 · DOI · Paper page
  46. Vahedi, 2015, Super-enhancers delineate disease-associated regulatory nodes in T cells, Nature, 520, 558, 10.1038/nature14154 · DOI · Paper page
  47. Liu, 1995, Cell stress and translational inhibitors transiently increase the abundance of mammalian Sine transcripts, Nucleic Acids Res., 23, 1758, 10.1093/nar/23.10.1758 · DOI · Paper page
  48. Stein, 2005, Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity, Cell, 121, 529, 10.1016/j.cell.2005.03.009 · DOI · Paper page
  49. Wolin, 2002, The LA protein, Annu. Rev. Biochem., 71, 375, 10.1146/annurev.biochem.71.090501.150003 · DOI · Paper page
  50. Porath, 2017, Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance, Genome Biol., 18, 185, 10.1186/s13059-017-1315-y · DOI · Paper page
  51. Bonaci-Nikolic, 2009, Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis, Lupus, 18, 78, 10.1177/0961203308093550 · DOI
  52. Crispin, 2005, Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis, Lupus, 14, 495
  53. Nortvedt, 1999, Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a, Mult. Scler., 5, 317, 10.1177/135245859900500503 · DOI
  54. Polman, 1995, The treatment of multiple-sclerosis - current and Future, Curr. Opin. Neurol., 8, 200, 10.1097/00019052-199506000-00008 · doi:10.1097/00019052-199506000-00008
  55. Goodkin, 1994, Interferon beta-1b, Lancet, 344, 1702, 10.1016/S0140-6736(94)90484-7 · doi:10.1016/s0140-6736(94)90484-7
  56. Myhr, 1999, Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis, Neurology, 52, 1049, 10.1212/WNL.52.5.1049 · DOI
  57. Panitch, 1987, Treatment of Multiple-Sclerosis with Gamma-interferon - exacerbations associated with activation of the immune-system, Neurology, 37, 1097, 10.1212/WNL.37.7.1097 · DOI · Paper page
  58. Arellano, 2017, Th1 and Th17 cells and associated cytokines discriminate among clinically isolated syndrome and multiple sclerosis phenotypes, Front. Immunol., 8, 753, 10.3389/fimmu.2017.00753 · DOI
  59. Su, 2014, Evolution of Alu elements toward enhancers, Cell Rep., 7, 376, 10.1016/j.celrep.2014.03.011 · DOI
  60. Guarda, 2011, Type I interferon inhibits interleukin-1 production and inflammasome activation, Immunity, 34, 213, 10.1016/j.immuni.2011.02.006 · DOI · Paper page
  61. Billiau, 2006, Anti-inflammatory properties of Type I interferons, Antivir. Res., 71, 108, 10.1016/j.antiviral.2006.03.006 · DOI
  62. Theofilopoulos, 2005, Type I interferons (alpha/beta) in immunity and autoimmunity, Annu. Rev. Immunol., 23, 307, 10.1146/annurev.immunol.23.021704.115843 · DOI · Paper page
  63. Aune, 1982, Activation of a suppressor T-cell pathway by interferon, Proc. Natl. Acad. Sci. U. S. A, 79, 3808, 10.1073/pnas.79.12.3808 · DOI

Cited by

Metadata

Authors
Heinrich, M. J., Purcell, C. A., Pruijssers, A. J., Zhao, Y., Spurlock, C. F., Sriram, S., Ogden, K. M., Dermody, T. S., Scholz, M. B., Crooke, P. S., Karijolich, J., & Aune, T. M.
Venue
Journal of Autoimmunity
Publisher
Elsevier BV
Published
2019-06
Volume
100
Pages
40-51
ISSN
0896-8411
Cited by
41
References
6
Language
en
Licence
Funders
  • National Institutes of Health (R01AI038296, R01AI044924, R21AI128281, R21AI144193, R44AI124766)
  • Vanderbilt University Medical Center
  • Københavns Universitet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.